A water-absorbent copolymer may include a vinyl alcohol constituent unit x and a constituent unit z other than the vinyl alcohol constituent unit x and a vinyl ester constituent unit y, wherein a ratio of a content of an average sequence of the constituent unit z to a content of the constituent unit z is 50.0 mol % or less.

A water-absorbent copolymer may include a vinyl alcohol constituent unit x and a constituent unit z other than the vinyl alcohol constituent unit x and a vinyl ester constituent unit y, wherein a ratio of a content of an average sequence of the constituent unit z to a content of the constituent unit z is 50.0 mol % or less.

An object of the present invention is to provide a PVA-based resin having a small distribution in degree of heat treatment in which the degree of heat treatment does not depend on a particle diameter. The polyvinyl alcohol-based resin of the present invention has an absorbance at 280 nm of 0.3 or more when being made to a 0.1 wt % aqueous solution and satisfies the following Formula (1): 0.9≤X.sub.1/Y.sub.1≤1.2 (in Formula (1), X.sub.1 represents an absorbance at 320 nm of a 0.1 wt % aqueous solution of a polyvinyl alcohol-based resin having a particle diameter larger than 1000 μm and 1680 μm or less, and Y.sub.1 represents an absorbance at 320 nm of a 0.1 wt % aqueous solution of a polyvinyl alcohol-based resin having a particle diameter larger than 212 μm and 500 μm or less).

An object of the present invention is to provide a PVA-based resin having a small distribution in degree of heat treatment in which the degree of heat treatment does not depend on a particle diameter. The polyvinyl alcohol-based resin of the present invention has an absorbance at 280 nm of 0.3 or more when being made to a 0.1 wt % aqueous solution and satisfies the following Formula (1): 0.9≤X.sub.1/Y.sub.1≤1.2 (in Formula (1), X.sub.1 represents an absorbance at 320 nm of a 0.1 wt % aqueous solution of a polyvinyl alcohol-based resin having a particle diameter larger than 1000 μm and 1680 μm or less, and Y.sub.1 represents an absorbance at 320 nm of a 0.1 wt % aqueous solution of a polyvinyl alcohol-based resin having a particle diameter larger than 212 μm and 500 μm or less).

A method of forming a particle includes, in a disperse phase within an aqueous suspension, polymerizing a plurality of mer units of a hydrophilic monomer having a hydrophobic protection group, thereby forming a polymeric particle including a plurality of the hydrophobic protection groups. The method further includes converting the polymeric particle to a hydrophilic particle.

A method of forming a particle includes, in a disperse phase within an aqueous suspension, polymerizing a plurality of mer units of a hydrophilic monomer having a hydrophobic protection group, thereby forming a polymeric particle including a plurality of the hydrophobic protection groups. The method further includes converting the polymeric particle to a hydrophilic particle.

A method of forming a particle includes, in a disperse phase within an aqueous suspension, polymerizing a plurality of mer units of a hydrophilic monomer having a hydrophobic protection group, thereby forming a polymeric particle including a plurality of the hydrophobic protection groups. The method further includes converting the polymeric particle to a hydrophilic particle.

The present invention provides a binder for a secondary battery having excellent binding force. A binder for a secondary battery comprising a polymer compound, wherein the polymer compound contains an acrylic repeating unit, and a 3% by mass aqueous solution of the polymer compound has a Hazen color of 10 or more and 400 or less.

The present invention provides a binder for a secondary battery having excellent binding force. A binder for a secondary battery comprising a polymer compound, wherein the polymer compound contains an acrylic repeating unit, and a 3% by mass aqueous solution of the polymer compound has a Hazen color of 10 or more and 400 or less.

Provided are a polymer medicament for treating hyperkalemia, and a preparation method thereof. Specifically, a polymer is provided, and the polymer includes repeating units obtained by polymerizing a monomer and a crosslinking agent. A molar ratio of the monomer to the crosslinking reagent ranges from 1:0.02 to 1:0.20. The monomer includes an acidic group and a pKa-reducing group next to the acidic group. The acidic group is selected from the group consisting of sulfonic acid group (—SO.sub.3—), sulfuric acid group (—OSO.sub.3—), carboxylic group (—CO.sub.2—), phosphonic acid group (—OPO.sub.3.sup.2—), phosphate group (—OPO.sub.3.sup.2—), and sulfamic acid group (—NHSO.sub.3—). The pKa-reducing group is selected from the group consisting of nitro, cyano, carbonyl, trifluoromethyl, and halogen atoms. The crosslinking agent has three or four reaction sites. The polymer can be used to treat hyperkalemia.